Theravance Biopharma (TBPH) Divestments (2020)
Theravance Biopharma (TBPH) posted quarterly Divestments of -$1.1 billion for Q4 2022, down 7416.0% quarter-over-quarter from $14.9 million in Q1 2020.
Powered by 
Analysis
Theravance Biopharma (TBPH) Divestments (2020) Analysis & Trends
Theravance Biopharma (TBPH) has reported Divestments for 2 consecutive years, with -$1.1 billion the latest figure, recorded in Q4 2022.
- In Q4 2022, Divestments changed N/A year-over-year to -$1.1 billion; the TTM figure through Dec 2022 stood at -$1.1 billion (changed N/A YoY), while the FY2022 annual figure was $2.7 million, changed N/A from the prior year.
- Divestments retreated to -$1.1 billion in Q4 2022 per TBPH's latest filing, from $14.9 million in the prior quarter.
- Across five years, Divestments topped out at $14.9 million in Q1 2020 and bottomed at -$1.1 billion in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Theravance Biopharma | 882.99 Mn | 495.33 Mn | - | - |